This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The Medicines and Healthcare products Regulatory Agency (MHRA) aims to launch a pilot genetic biobank that will gather patient data to associate drug-related adverse events to their genetic makeup. According to the press release, the MHRA will be the first drug safety regulator in the world to pilot such a biobank.
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved an updated version of Moderna’s COVID-19 vaccine, Spikevax, that targets two coronavirus variants as a booster. The regulator confirmed that the vaccine meets its standards of safety, quality and effectiveness.
It has been conditionally authorised by the UK Medicines and Healthcare products Regulatory Agency (MHRA) as a gene-editing therapy for certain patients 12 years old and over with sickle-cell disease and transfusion-dependent β-thalassemia. Sideeffects from treatment were similar to those associated with autologous stem cell transplants.
It has been granted marketing authorisation by the Medicines and Healthcare Products Regulatory Agency (MHRA) in Great Britain. The most common sideeffects observed were initial insomnia, irritability and dyskinesia. The product, produced by biopharma company PTC Therapeutics, is approved for patients 18 months and over.
Artificial intelligence (AI) is rapidly transforming the healthcare industry, with its ability to process and analyze vast amounts of data. However, not all patients respond well to immunotherapy and it can have significant sideeffects. Even just a year ago, we couldn’t fathom a cure for cancer. Now, we can.
The decision follows approval by the Medicines and Healthcare products Regulatory Agency (MHRA) last Saturday, which gave the green light for use of the new vaccine in those aged 12 years and above. Data from a clinical trial found sideeffects to typically be mild and self-resolving and to be no worse than the original booster dose.
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted conditional authorisation for Moderna ’s Covid-19 booster vaccine, mRNA-1273.214 (Spikevax Bivalent Original/Omicron), for use in adults aged 18 years and above. In addition, no serious safety concerns linked to the vaccine were observed.
The Medicines and Healthcare products Regulatory Agency (MHRA) has authorised Comirnaty ® , the Pfizer/BioNTech COVID-19 vaccine for infants and children aged six months to four years in Great Britain. The common, expected sideeffects were within expectations for a vaccine in this age group.
On 29 November, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) warned of some new and potentially serious eye-related sideeffects associated with Dupixent, an interleukin (IL)-4/13 inhibitor drug used in the treatment of numerous allergic indications such as atopic dermatitis, asthma and nasal polyps.
Pharmaceutical marketing is a critical aspect of the industry, as it helps in spreading awareness about the benefits and potential sideeffects of different drugs. In recent years, digital marketing has become an increasingly important tool for pharmaceutical companies to reach patients and healthcare providers.
Consequently, there’s a strong collective yearning for experiences that evoke the desire to savor and provoke wonder, discovery, and fascination, while feeling rooted in our shared humanity — offering safety and healing. In a category like healthcare, wellness is often depicted superficially, with a breadth of an inch and depth of a mile.
Two of the biggest challenges facing healthcare R&D are the sheer volume of data and the unique characteristics of every person’s health. Learn more about the role of AI in drug development and how healthcare researchers are using it to shake up the field. Artificial intelligence (AI) and other technologies offer a way forward.
But the role of AI in healthcare will go beyond this. healthcare, with its 17% share of GDP, is “the most disruptable industry in the world,” and “the first big carcass that AI is going to start to feed on.” It provides guidance and acts as a safety net for prescribers. And there’s more to come. AI isn’t coming for your job.
By incorporating a more comprehensive range of individuals in clinical trials, researchers can obtain valuable insights into the efficacy and safety of drugs across various populations. For organisations looking to standardise the measurement of safety data, what approach is the most impactful?
Non-invasive healthcare products refer to medical devices or technologies that do not require puncturing the skin or entering the body in any way to diagnose, treat, or monitor a health condition. They are designed to be safe and comfortable for patients, and typically have minimal sideeffects.
“They are effective but too expensive for the majority of patients, even with insurance coverage,” said one primary care physician (PCP). And while they’re excited about the drugs’ results and limited sideeffects now, many also noted concerns about the lack of safety data and long-term risks.
Healthcare is notoriously conservative in its adoption of technology. With the sudden physical distance between patients and healthcare facilities imposed by the lockdown, providers proved they could transition to virtual care instantly. Now with the appropriate safety measures in place, they are urging patients to come back.
There have been great strides made in genomics to refine tools that determine the safest, most effective course of treatments for patients across a number of disease states. This means that hyper-metabolisers would need their dosage to be increased to achieve the desired effect.
Selling to private practice doctors is different than selling to healthcare organizations. To convince doctors that a product is worth recommending to their patients you need to have strong evidence supporting both its effectiveness and its safety.
This includes in-depth knowledge of the science behind the products, as well as their indications, contraindications, and potential sideeffects. This helps me to be able to answer any question or concern a healthcare provider may have about the product. But product knowledge is not the only important aspect of my job.
It also underscores the need for patients to communicate openly with their healthcare providers about any health concerns or issues they may have. This includes potential sideeffects or adverse reactions to medications. This is before a drug can be approved for public use.
The UK healthcare sector is mourning one of the most eminent of its figures in the last few decades – Professor Sir Mike Rawlins – who has passed away at the age of 81. ” The post Tributes as former NICE, MHRA chair Sir Mike Rawlins dies appeared first on.
These treatments at times come with a long list of sideeffects, leaving many patients in search of an effective long-term solution. For some patients with PTSD, psychotherapy may not be an effective option, they may find talking about their traumatic experience stress inducing, untherapeutic or ineffective.
According to the 2021 Accenture Healthcare Experience Survey, 52% of patients say having emotional support is important to having a positive healthcare experience. Housing, access to food and transportation, as well as the ability to pay for healthcare and medicine are just a few economic barriers to medical adherence.
One reason for this growth is an increasing demand for personalized healthcare technologies as patients look for advances in how healthcare is delivered following the pandemic. NovaXS is on a mission to simplify the medication self-administration process and improve remote healthcare adherence. billion in 2030 at a CAGR of 9.2%.
In theory, this will allow for highly tailored, personalized therapy plans with superior efficacy and minimal sideeffects. To avoid compliance issues , it is essential to keep up with new regulatory changes, including updated reporting guidelines and safety requirements.
healthcare system but we haven’t seen widespread acceptance by doctors and patients. AI also helps drive brands’ strategies on which message should be seen in which channel—for example, information on clinical efficacy, safety, formulary status, or interchangeability designation—and when that message will be most effective.
Pegozafermin also has a favourable safety and tolerability profile, with few gastrointestinal (GI) sideeffects. The ability to reverse disease progression, resulting in fewer liver transplants and treatments, could save the healthcare system billions annually. It is becoming the leading cause for liver transplants.
Imagine having a tool that allows you to target specific audiences actively searching for healthcare solutions, like branded medications or treatment options. In a world where patients and healthcare professionals (HCPs) search for drug information online, PPC lets you stay top-of-mind. PPC does just that. Simple: visibility.
Its about reaching healthcare professionals (HCPs), patients, and stakeholders through targeted, value-driven messaging. Real-Time Feedback: Use platforms like Veeva CRM to gauge the effectiveness of your campaigns. Highlight unique selling points (USPs) like safety profiles, ease of use, or long-term outcomes.
In the United States, vaccine hesitancy is often observed among families with lower levels of education, lower socioeconomic status, and concerns about vaccine safety and sideeffects Addressing concerns and providing accurate information to counter misinformation are crucial steps to overcome vaccine hesitancy.
We were drilled on the science behind our medications, their benefits, potential sideeffects, and the competitive landscape. We were the bridge between the pharmaceutical companies and the healthcare providers, and our credibility depended on our knowledge and communication skills.
A step-by step guide on the benefits, processes, and key considerations involved in the Healthcare Technology Assessment (HTA) Early Scientific Advice (ESA) consultation as part of planning the holistic evidence generation to support the design of an asset. In recent years, the biopharma market has become progressively complex.
In the competitive landscape of the pharmaceutical industry, effective marketing strategies are crucial for brand success. Pharmaceutical marketing is not just about reaching healthcare professionals and patients; it involves a complex interplay of understanding market dynamics, regulatory compliance, and leveraging digital platforms.
But before pharmaceutical companies can go to market with a breakthrough drug, they need to ensure safety and efficacy through clinical trials. Pharma companies need tools like AI that can reliably improve this percentage without jeopardizing safety. The need for new medical treatments and drugs has never been greater.
Speciality pharmacies play a crucial role in medication dosing, disease and sideeffects management, and patient care. The expert services rendered by them help in improving patient outcomes, minimising costs of the healthcare system, improving medicinal adherence and persistency and saving clinicians’ time.
While new positive clinical data with anti-Abeta mAbs signal tremendous advancement and proof‑of-concept for the whole field, it is believed that the observed effects could still be improved and optimised in terms of greater clinical benefits, lower sideeffects and enhanced treatment convenience.
Real-world data (RWD) is a critical tool for advancing healthcare innovation, improving health outcomes, lowering the cost of care, improving healthcare quality, reducing barriers to access, and closing health disparities. This approach leads to more targeted and effective provider engagement strategies and patient support programs.
However, the high cost associated with the drugs, along with spotty reimbursement and sideeffects, could prompt some patients to reconsider a surgical approach whose safety and efficacy are well understood. Device-based treatments for comorbidities associated with obesity will also see an impact.
The pharmaceutical industry is one of the most heavily regulated sectors due to the direct impact of its products on public health and safety. Several factors contribute to the stringent regulatory environment: Patient Safety: Ensuring that the pharmaceutical products are safe and effective is a crucial aspect.
Merck’s exit came after other companies including Pfizer, Eli Lilly and Roche all scrapped CETP development programmes following safety or efficacy issues. Others were let down not by safety but efficacy, with anacetrapib coming closest to showing value in a phase 3 trial.
A generic here will improve access in OAB to a product with less sideeffects, which is especially important in the elderly population, Casberg noted. A generic here will improve access in OAB to a product with less sideeffects, which is especially important in the elderly population, Casberg noted.
Three effective strategies that have been proven to work are: Developing personalized patient-friendly resources that are easy to understand. Support healthcare providers in a real and personal way. It is a bridge between where we are in healthcare today and where we want to go tomorrow. print, online, video).
By understanding these strategies, stakeholders in the pharmaceutical industry can better navigate the complexities of promoting their products effectively. One of the primary objectives of pharma marketing is to communicate the benefits and safety profiles of medications to healthcare providers and patients.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content